$TGNT
Totaligent, Inc.

2024 Q4 Form 10-Q Financial Statement

#000147793224007905 Filed on December 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024 Q2
Revenue $29.99K $73.61K
YoY Change -91.03% 22.71%
Cost Of Revenue $37.42K $44.24K
YoY Change -37.58% 346.23%
Gross Profit -$7.432K $29.37K
YoY Change -102.71% -41.35%
Gross Profit Margin -24.78% 39.89%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.383K
YoY Change 64.9%
% of Gross Profit 14.93%
Operating Expenses $451.1K $135.2K
YoY Change 26.69% 5.26%
Operating Profit -$458.5K -$105.9K
YoY Change 460.35% 35.03%
Interest Expense $11.85K $11.29K
YoY Change 36.37% 40.52%
% of Operating Profit
Other Income/Expense, Net $94.50K $94.50K
YoY Change -18.67% 0.0%
Pretax Income -$575.4K -$123.8K
YoY Change 236.8% 148.8%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$575.4K -$123.8K
YoY Change 236.8% 148.8%
Net Earnings / Revenue -1918.72% -168.19%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 172.9M shares 172.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $8.448K $21.63K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $1.086M
Receivables
Other Receivables
Total Short-Term Assets $1.095M $205.6K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $67.06K $76.16K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $168.9K $157.2K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.095M $205.6K
Total Long-Term Assets $168.9K $157.2K
Total Assets $1.264M $362.8K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.809M $1.537M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.809M $1.537M
Total Long-Term Liabilities
Total Liabilities $1.809M $1.537M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.695M $1.124M
YoY Change
Common Stock $211.1K $211.1K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $972.2K
YoY Change
Treasury Stock Shares
Shareholders Equity -$544.7K -$1.174M
YoY Change
Total Liabilities & Shareholders Equity $1.264M $362.8K
YoY Change

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$575.4K -$123.8K
YoY Change 236.8% 148.8%
Depreciation, Depletion And Amortization $4.383K
YoY Change 64.9%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
6467 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
603750 shares
dei Entity Central Index Key
EntityCentralIndexKey
0000846377
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
713750 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
603750 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211101313 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172913813 shares
CY2023Q4 totaligent Treasury Stock Shares Outstanding
TreasuryStockSharesOutstanding
38187500 shares
CY2023Q4 totaligent Shares To Be Issued Shares
SharesToBeIssuedShares
5476967 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55122
dei Entity Registrant Name
EntityRegistrantName
TOTALIGENT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0142655
dei Entity Address Address Line1
EntityAddressAddressLine1
2255 Glades Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 324A
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
988-2621
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172913813 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8448 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167735 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1086473 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
190213 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1094921 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
357948 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67057 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89544 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
101808 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
39308 usd
CY2024Q3 us-gaap Assets
Assets
1263786 usd
CY2023Q4 us-gaap Assets
Assets
486800 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
899193 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
655395 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
112308 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
77876 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
808 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
580830 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
514363 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
216186 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
149182 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1808517 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1396816 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1808517 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1396816 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
713750 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
7138 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
6038 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211101313 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172913813 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
211101 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
211101 usd
CY2024Q3 totaligent Shares Yet To Be Issued Amount
SharesYetToBeIssuedAmount
5476 usd
CY2023Q4 totaligent Shares Yet To Be Issued Amount
SharesYetToBeIssuedAmount
5486 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1898577 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
699667 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1694842 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-860127 usd
CY2024Q3 totaligent Treasury Stock Shares Outstanding
TreasuryStockSharesOutstanding
38187500 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
972181 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
972181 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-544731 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-910016 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1263786 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
486800 usd
CY2024Q3 us-gaap Revenues
Revenues
29990 usd
CY2023Q3 us-gaap Revenues
Revenues
334185 usd
us-gaap Revenues
Revenues
444529 usd
us-gaap Revenues
Revenues
400295 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
37422 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
59956 usd
us-gaap Cost Of Revenue
CostOfRevenue
415923 usd
us-gaap Cost Of Revenue
CostOfRevenue
81541 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
-7432 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
274229 usd
us-gaap Gross Profit
GrossProfit
28606 usd
us-gaap Gross Profit
GrossProfit
318754 usd
CY2024Q3 totaligent Consulting Expenses
ConsultingExpenses
312500 usd
CY2023Q3 totaligent Consulting Expenses
ConsultingExpenses
209745 usd
totaligent Consulting Expenses
ConsultingExpenses
352905 usd
totaligent Consulting Expenses
ConsultingExpenses
218900 usd
CY2024Q3 us-gaap Other Expenses
OtherExpenses
94500 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
116188 usd
us-gaap Other Expenses
OtherExpenses
288500 usd
us-gaap Other Expenses
OtherExpenses
305188 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44072 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30120 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114013 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
69291 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
451072 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
356053 usd
us-gaap Operating Expenses
OperatingExpenses
755418 usd
us-gaap Operating Expenses
OperatingExpenses
593379 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-458504 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-81824 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-726812 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-274625 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
11853 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
8692 usd
us-gaap Interest Expense
InterestExpense
34432 usd
us-gaap Interest Expense
InterestExpense
24753 usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6467 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-105066 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-80334 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-67004 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-28408 usd
CY2024Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2023Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-38254 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-116919 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-89026 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-107903 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-91415 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-575423 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-170850 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-834715 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-366040 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-575423 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-170850 usd
us-gaap Net Income Loss
NetIncomeLoss
-834715 usd
us-gaap Net Income Loss
NetIncomeLoss
-366040 usd
CY2024Q3 totaligent Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2023Q3 totaligent Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
totaligent Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
totaligent Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2024Q3 totaligent Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
211101313 shares
CY2023Q3 totaligent Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
159655077 shares
totaligent Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
211101313 shares
totaligent Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
160932855 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-910016 usd
CY2024Q1 totaligent Series D Preferred Stock Issued For Services Amount
SeriesDPreferredStockIssuedForServicesAmount
0 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-140490 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1050506 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-123802 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1174308 usd
CY2024Q3 totaligent Series D Preferred Stock Issued For Services Amount
SeriesDPreferredStockIssuedForServicesAmount
1200000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-570423 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-544731 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-761094 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-145431 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-906525 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2023Q2 totaligent Convertible Preferred Stock Value Issued Upon Conversion
ConvertiblePreferredStockValueIssuedUponConversion
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-49759 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-931284 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
28248 usd
CY2023Q3 totaligent Series D Preferred Stock Converted Into Common Stock Amount
SeriesDPreferredStockConvertedIntoCommonStockAmount
0 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-170850 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1073886 usd
us-gaap Profit Loss
ProfitLoss
-834715 usd
us-gaap Profit Loss
ProfitLoss
-366040 usd
us-gaap Depreciation
Depreciation
21623 usd
us-gaap Depreciation
Depreciation
7974 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1200000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6467 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-38254 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-67004 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-28408 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
896260 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1804 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
243798 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
266684 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
34430 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
24752 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3305 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-157653 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5077 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16071 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
61634 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61634 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16071 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
60000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
185000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
18159 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
191841 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-159287 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
202835 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167735 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14001 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8448 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
216836 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
totaligent Conversion Of Convertible Securities Notes Payable
ConversionOfConvertibleSecuritiesNotesPayable
0 usd
totaligent Conversion Of Convertible Securities Notes Payable
ConversionOfConvertibleSecuritiesNotesPayable
28248 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. </strong><strong>Nature of operations</strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 3, 2021, Totaligent, a Delaware corporation, Digi Messaging &amp; Advertising Inc., a Wyoming corporation (“Digi” or the “Company”), and the Shareholders of the Company (the “Digi Shareholders”) executed an Agreement and Plan of Merger (the “Merger Agreement”) that provided for Digi to be merged into Totaligent (the “Merger”) through a share exchange agreement. As a result of the Share Exchange, Totaligent acquired 100% of the issued and outstanding shares of Digi in exchange for the issuance of 600,000 shares of Series D Convertible Preferred Stock. On July 21, 2022, the Company changed its name to Totaligent, Inc. (“Totaligent” or the “Company”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Immediately following the Merger, Totaligent’s subsidiary, CSES Group, Inc., which owns all rights, title and interest in Totaligent’s refrigerant technology, was spun out in exchange for the cancellation of an aggregate of 54,422,903 shares of Totaligent Common Stock (the “Cancelled Shares”) held by former Totaligent management and shareholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon completion of these actions, Edward C. DeFeudis was appointed to the role of CEO and Ben Hansel remained on the board of directors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s common stock was traded under the symbol “LTMP” on the OTCQB through May 20, 2018, on the OTC Pink marketplace thereafter, and trades under the symbol “TGNT” as of August 1, 2022.</p>
us-gaap Net Income Loss
NetIncomeLoss
-834715 usd
CY2024Q3 totaligent Working Capital Deficit
WorkingCapitalDeficit
-713596 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1694842 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-544731 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8448 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
167735 usd
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.10 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
751452759 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
648131148 shares
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
143275 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
143275 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
76218 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
53731 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67057 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
89544 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18964 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
18222 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8233 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5395 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
101808 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
39308 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
101808 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
39308 usd
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
580830 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
520830 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
580830 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
520830 usd
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2024Q3 totaligent Unamortized Discount
UnamortizedDiscount
0 usd
CY2023Q4 totaligent Unamortized Discount
UnamortizedDiscount
6467 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
580830 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
514363 usd
us-gaap Debt Conversion Description
DebtConversionDescription
The conversion price is the average closing bid price for the 10 trading days prior to the conversion date multiplied by 80%, not to exceed $0.01
CY2024Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.01
CY2024Q3 totaligent Common Shares Of Derivative Liability
CommonSharesOfDerivativeLiability
37702759 usd
CY2024Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
216186 usd
CY2023Q4 totaligent Common Shares Of Derivative Liability
CommonSharesOfDerivativeLiability
45221645 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
149182 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
0 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
0 usd
totaligent Gain On Change In Fair Value Of Derivative Liabilities
GainOnChangeInFairValueOfDerivativeLiabilities
-67004 usd
totaligent Gain On Change In Fair Value Of Derivative Liabilities
GainOnChangeInFairValueOfDerivativeLiabilities
-28408 usd
CY2024Q3 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
0 usd
CY2023Q3 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
0 usd
CY2024Q3 totaligent Gain On Change In Fair Value Of Derivative Liabilities
GainOnChangeInFairValueOfDerivativeLiabilities
-105066 usd
CY2023Q3 totaligent Gain On Change In Fair Value Of Derivative Liabilities
GainOnChangeInFairValueOfDerivativeLiabilities
-80334 usd
CY2019Q3 totaligent Quoted Market Price On Valuation Date
QuotedMarketPriceOnValuationDate
0.034
CY2023 totaligent Quoted Market Price On Valuation Date
QuotedMarketPriceOnValuationDate
0.012
totaligent Quoted Market Price On Valuation Date
QuotedMarketPriceOnValuationDate
0.016
CY2019Q3 totaligent Effective Contractual Conversion Rates
EffectiveContractualConversionRates
0.026
CY2023 totaligent Effective Contractual Conversion Rates
EffectiveContractualConversionRates
0.009
totaligent Effective Contractual Conversion Rates
EffectiveContractualConversionRates
0.012
CY2019Q3 totaligent Contractual Term To Maturity
ContractualTermToMaturity
P0Y6M
CY2023 totaligent Contractual Term To Maturity
ContractualTermToMaturity
P0Y3M
totaligent Contractual Term To Maturity
ContractualTermToMaturity
P0Y3M
CY2019Q3 totaligent Risk Adjusted Interest Rate
RiskAdjustedInterestRate
0.10 pure
CY2023 totaligent Risk Adjusted Interest Rate
RiskAdjustedInterestRate
0.10 pure
totaligent Risk Adjusted Interest Rate
RiskAdjustedInterestRate
0.10 pure
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
149182 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
161565 usd
totaligent Embedded Derivatives
EmbeddedDerivatives
0 usd
CY2023 totaligent Embedded Derivatives
EmbeddedDerivatives
26376 usd
totaligent Conversions Extinguishments
ConversionsExtinguishments
0 usd
CY2023 totaligent Conversions Extinguishments
ConversionsExtinguishments
0 usd
totaligent Changes In Fair Value Inputs And Assumptions Reflected In Income
ChangesInFairValueInputsAndAssumptionsReflectedInIncome
67004 usd
CY2023 totaligent Changes In Fair Value Inputs And Assumptions Reflected In Income
ChangesInFairValueInputsAndAssumptionsReflectedInIncome
-38759 usd
CY2024Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
216186 usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
149182 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
211101313 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
172913813 shares
CY2024Q3 totaligent Shares To Be Issued Shares
SharesToBeIssuedShares
5476967 shares
CY2024Q3 totaligent Treasury Stock Shares Outstanding
TreasuryStockSharesOutstanding
38187500 shares
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
440659 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
223633 usd
CY2024Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
217026 usd
CY2023Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23898 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1694842 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.05 pure
totaligent Effectiveincometaxratereconciliationchange In Valuation Allowance
EffectiveincometaxratereconciliationchangeInValuationAllowance
0.26 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure

Files In Submission

Name View Source Status
0001477932-24-007905-index-headers.html Edgar Link pending
0001477932-24-007905-index.html Edgar Link pending
0001477932-24-007905.txt Edgar Link pending
0001477932-24-007905-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
totaligent-20240930.xsd Edgar Link pending
totaligent-20240930_cal.xml Edgar Link unprocessable
totaligent_10q.htm Edgar Link pending
totaligent_ex311.htm Edgar Link pending
totaligent_ex312.htm Edgar Link pending
totaligent_ex321.htm Edgar Link pending
totaligent_ex322.htm Edgar Link pending
totaligent-20240930_pre.xml Edgar Link unprocessable
totaligent_10q_htm.xml Edgar Link completed
totaligent-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
totaligent-20240930_lab.xml Edgar Link unprocessable